191
Views
7
CrossRef citations to date
0
Altmetric
Letter

Hematologic improvement after flavopiridol treatment of pentostatin and rituximab refractory hairy cell leukemia

, , , &
Pages 490-491 | Received 09 May 2011, Accepted 16 Jun 2011, Published online: 13 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Preetesh Jain, Aaron Polliack & Farhad Ravandi. (2015) Novel therapeutic options for relapsed hairy cell leukemia. Leukemia & Lymphoma 56:8, pages 2264-2272.
Read now
Prithviraj Bose, Gary L Simmons & Steven Grant. (2013) Cyclin-dependent kinase inhibitor therapy for hematologic malignancies. Expert Opinion on Investigational Drugs 22:6, pages 723-738.
Read now

Articles from other publishers (5)

Nobumoto Watanabe & Hiroyuki Osada. 2017. Bioprobes. Bioprobes 11 35 .
Loredana Santo, Ka Tat Siu & Noopur Raje. (2015) Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers. Seminars in Oncology 42:6, pages 788-800.
Crossref
Preetesh Jain, Naveen Pemmaraju & Farhad Ravandi. (2014) Update on the Biology and Treatment Options for Hairy Cell Leukemia. Current Treatment Options in Oncology 15:2, pages 187-209.
Crossref
V Maevis, U Mey, G Schmidt-Wolf & I G H Schmidt-Wolf. (2014) Hairy cell leukemia: short review, today’s recommendations and outlook. Blood Cancer Journal 4:2, pages e184-e184.
Crossref
Robert J. Kreitman. (2012) Immunoconjugates and new molecular targets in hairy cell leukemia. Hematology 2012:1, pages 660-666.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.